126 related articles for article (PubMed ID: 28522850)
1. Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination.
Bouillot S; Munro P; Gallet B; Reboud E; Cretin F; Golovkine G; Schoehn G; Attrée I; Lemichez E; Huber P
Sci Rep; 2017 May; 7(1):2120. PubMed ID: 28522850
[TBL] [Abstract][Full Text] [Related]
2. A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
Elsen S; Huber P; Bouillot S; Couté Y; Fournier P; Dubois Y; Timsit JF; Maurin M; Attrée I
Cell Host Microbe; 2014 Feb; 15(2):164-76. PubMed ID: 24528863
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis.
Basso P; Ragno M; Elsen S; Reboud E; Golovkine G; Bouillot S; Huber P; Lory S; Faudry E; Attrée I
mBio; 2017 Jan; 8(1):. PubMed ID: 28119472
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa ExlA and Serratia marcescens ShlA trigger cadherin cleavage by promoting calcium influx and ADAM10 activation.
Reboud E; Bouillot S; Patot S; Béganton B; Attrée I; Huber P
PLoS Pathog; 2017 Aug; 13(8):e1006579. PubMed ID: 28832671
[TBL] [Abstract][Full Text] [Related]
5. Exolysin Shapes the Virulence of Pseudomonas aeruginosa Clonal Outliers.
Reboud E; Basso P; Maillard AP; Huber P; Attrée I
Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29120408
[TBL] [Abstract][Full Text] [Related]
6. cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers.
Berry A; Han K; Trouillon J; Robert-Genthon M; Ragno M; Lory S; Attrée I; Elsen S
J Bacteriol; 2018 Jun; 200(12):. PubMed ID: 29632090
[TBL] [Abstract][Full Text] [Related]
7. Exolysin (ExlA) from Pseudomonas aeruginosa Punctures Holes into Target Membranes Using a Molten Globule Domain.
Bertrand Q; Job V; Maillard AP; Imbert L; Teulon JM; Favier A; Pellequer JL; Huber P; Attrée I; Dessen A
J Mol Biol; 2020 Jul; 432(16):4466-4480. PubMed ID: 32504624
[TBL] [Abstract][Full Text] [Related]
8. Inflammasome activation by Pseudomonas aeruginosa's ExlA pore-forming toxin is detrimental for the host.
Bouillot S; Pont S; Gallet B; Moriscot C; Deruelle V; Attrée I; Huber P
Cell Microbiol; 2020 Nov; 22(11):e13251. PubMed ID: 32779854
[TBL] [Abstract][Full Text] [Related]
9. ExlA: A New Contributor to
Huber P
Front Cell Infect Microbiol; 2022; 12():929150. PubMed ID: 35811671
[TBL] [Abstract][Full Text] [Related]
10. Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide.
Reboud E; Elsen S; Bouillot S; Golovkine G; Basso P; Jeannot K; Attrée I; Huber P
Environ Microbiol; 2016 Oct; 18(10):3425-3439. PubMed ID: 26914644
[TBL] [Abstract][Full Text] [Related]
11. ExlA Pore-Forming Toxin: Localization at the Bacterial Membrane, Regulation of Secretion by Cyclic-Di-GMP, and Detection In Vivo.
Deruelle V; Berry A; Bouillot S; Job V; Maillard AP; Elsen S; Huber P
Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564649
[TBL] [Abstract][Full Text] [Related]
12. Multiple Pseudomonas species secrete exolysin-like toxins and provoke Caspase-1-dependent macrophage death.
Basso P; Wallet P; Elsen S; Soleilhac E; Henry T; Faudry E; Attrée I
Environ Microbiol; 2017 Oct; 19(10):4045-4064. PubMed ID: 28654176
[TBL] [Abstract][Full Text] [Related]
13. PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury.
Wang Q; Li H; Zhou J; Zhong M; Zhu D; Feng N; Liu F; Bai C; Song Y
Respir Physiol Neurobiol; 2014 Mar; 193():21-8. PubMed ID: 24418353
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia.
Le Berre R; Nguyen S; Nowak E; Kipnis E; Pierre M; Quenee L; Ader F; Lancel S; Courcol R; Guery BP; Faure K;
Crit Care Med; 2011 Sep; 39(9):2113-20. PubMed ID: 21572326
[TBL] [Abstract][Full Text] [Related]
15. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
Sawa T; Ito E; Nguyen VH; Haight M
Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
[TBL] [Abstract][Full Text] [Related]
16. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins.
Faure K; Sawa T; Ajayi T; Fujimoto J; Moriyama K; Shime N; Wiener-Kronish JP
Respir Res; 2004 Feb; 5(1):1. PubMed ID: 15040820
[TBL] [Abstract][Full Text] [Related]
17. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
[TBL] [Abstract][Full Text] [Related]
18. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature.
Thanabalasuriar A; Surewaard BG; Willson ME; Neupane AS; Stover CK; Warrener P; Wilson G; Keller AE; Sellman BR; DiGiandomenico A; Kubes P
J Clin Invest; 2017 Jun; 127(6):2249-2261. PubMed ID: 28463232
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of a type III secretion system (T3SS) and of a new effector protein from a clinical isolate of Aeromonas hydrophila--part I.
Sha J; Wang SF; Suarez G; Sierra JC; Fadl AA; Erova TE; Foltz SM; Khajanchi BK; Silver A; Graf J; Schein CH; Chopra AK
Microb Pathog; 2007 Oct; 43(4):127-46. PubMed ID: 17644303
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa type-3 secretion system dampens host defense by exploiting the NLRC4-coupled inflammasome.
Faure E; Mear JB; Faure K; Normand S; Couturier-Maillard A; Grandjean T; Balloy V; Ryffel B; Dessein R; Chignard M; Uyttenhove C; Guery B; Gosset P; Chamaillard M; Kipnis E
Am J Respir Crit Care Med; 2014 Apr; 189(7):799-811. PubMed ID: 24555512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
